Skip to Content

APO 046 125 (Divalproex Sodium Delayed-Release 125 mg)

Pill with imprint APO 046 125 is White, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 125 mg. It is supplied by Apotex Corp..

Divalproex sodium is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO 046 125

Divalproex sodium delayed-release 125 mg APO 046 125

Divalproex Sodium Delayed-Release

Imprint:
APO 046 125
Strength:
125 mg
Color:
White
Size:
12.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Corp.
Inactive Ingredients:
hypromellose
methacrylic acid - ethyl acrylate copolymer (1:1) type a
microcrystalline cellulose
polyethylene glycol
magnesium silicate
titanium dioxide
triethyl citrate
hydroxypropyl cellulose
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide